日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Self-Adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery.

用于靶向肿瘤定植和局部治疗药物递送的自调节工程益生菌

Zou Zhen-Ping, Wang Xin-Ge, Shi Xuan-Ren, Sun Shu-Ting, Mi Jing, Zhang Xiao-Peng, Yin Bin-Cheng, Zhou Ying, Ye Bang-Ce

Gut microbiota and associated metabolites: key players in high-fat diet-induced chronic diseases

肠道菌群及其相关代谢产物:高脂饮食诱发慢性疾病的关键因素

Du, Wei; Zou, Zhen-Ping; Ye, Bang-Ce; Zhou, Ying

Development of ultrasound-visualized tumor-targeting engineered bacteria for precise tumor therapy

开发超声可视化肿瘤靶向工程细菌用于精准肿瘤治疗

Qu, Li; Chi, Zhou; Zou, Zhen-Ping; Zhou, Ying; Ye, Bang-Ce

Empowering probiotics with high xanthine transport for effective hyperuricemia management

赋予益生菌高黄嘌呤转运能力,以有效管理高尿酸血症

Zou, Zhen-Ping; Li, Ju-Ling; Zhang, Yi-Fan; Zhou, Ying; Ye, Bang-Ce

Dual engineered bacteria improve inflammatory bowel disease in mice

双工程细菌可改善小鼠炎症性肠病

Wu, Yong-Qi; Zou, Zhen-Ping; Zhou, Ying; Ye, Bang-Ce

Genetically engineered bacteria as inflammatory bowel disease therapeutics

基因工程细菌作为炎症性肠病疗法

Zou, Zhen-Ping; Zhang, Xiao-Peng; Zhang, Qian; Yin, Bin-Cheng; Zhou, Ying; Ye, Bang-Ce

Acylation driven by intracellular metabolites in host cells inhibits Cas9 activity used for genome editing

宿主细胞内代谢物驱动的酰化作用会抑制用于基因组编辑的Cas9活性。

Zhao, Li; You, Di; Wang, Ting; Zou, Zhen-Ping; Yin, Bin-Cheng; Zhou, Ying; Ye, Bang-Ce